HIV Infections: all 4,340 studies

Page 9 of 44. Open to participants first (240), then studies with results posted, then the rest; newest registration first within each.

• Drug Use Investigation On Zithromac (Azithromycin) In HIV PatientsCompletedNCT01227395Results posted
• Reducing Heavy Drinking to Optimize HIV/AIDS Treatment and PreventionCompletedNCT01227044Phase 2/3Results posted
• A Study to Assess the Efficacy of Raltegravir (Isentress®), Administered in Combination With Other Antiretroviral Drugs as Treatment for Adults and Older Adults Infected With the Human Immunodeficiency Virus 1 (HIV-1)(MK-0518-145) (Wirksamkeit Von Isentress® Unter Praxisbedingungen)CompletedNCT01213316Results posted
• R5 Integrase Study in HIV-1 Naive PatientsCompletedNCT01204905Not applicableResults posted
• A Study of the Once Daily Combination of Etravirine and Darunavir/Ritonavir As Dual Therapy in Early Treatment-Experienced PatientsCompletedNCT01199939Phase 2Results posted
• Dose-finding Study of GSK2248761 in Antiretroviral Therapy-experienced Subjects With NNRTI-resistant HIV InfectionTerminatedNCT01199731Phase 2Results posted
• Atripla to Raltegravir Switch Study for CNS ToxicityCompletedNCT01195467Phase 3Results posted
• Raltegravir With Optimized Background Therapy (OBT) in Multiple Experienced HIV-infected PatientsCompletedNCT01190124Results posted
• A Controlled Trial to Evaluate the Effects of GanedenBC30 on the Immune SystemCompletedNCT01184456Phase 2Results posted
• Home Self-Testing for HIV to Increase HIV Testing Frequency in Men Who Have Sex With Men (The iTest Study)CompletedNCT01161446Not applicableResults posted
• A Comparison of Body Fat Distribution in HIV-1 Infected Patients Receiving, Since the Beginning and for at Least Two Years, an Antiretroviral Therapy Based on Efavirenz or Lopinavir/Ritonavir Combined With Tenofovir + Emtricitabine or LamivudineCompletedNCT01159743Results posted
• Effects of Intensive cART During Acute/Early HIV InfectionCompletedNCT01154673Phase 2/3Results posted
• Long-term Effectiveness and Safety in Hepatitis-co-infected PatientsCompletedNCT01153269Results posted
• Treatment Options for Protease Inhibitor-exposed ChildrenCompletedNCT01146873Phase 3Results posted
• Clinical Study of TUTI-16 in HIV-1 Infected and Uninfected SubjectsCompletedNCT01144026Phase 1/2Results posted
• Non-interventional Observational Study With Viramune® in HIV to Evaluate Gender Specific DataCompletedNCT01134939Results posted
• H1N1 Influenza Vaccine Immunogenicity in HIV-1 Infected PatientsCompletedNCT01111162Phase 4Results posted
• Safety and Efficacy of COBI-boosted Atazanavir Versus Ritonavir-boosted Atazanavir Each Administered With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive AdultsCompletedNCT01108510Phase 3Results posted
• Heart Function in HIV-Negative Children Exposed to HIV and HAARTCompletedNCT01107834Results posted
• Study to Evaluate the Safety and Efficacy of Stribild Versus Ritonavir-Boosted Atazanavir Plus Truvada in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive AdultsCompletedNCT01106586Phase 3Results posted
• A Simplification Study of Unboosted Reyataz With Epzicom (ASSURE)CompletedNCT01102972Phase 4Results posted
• PRINCE: Study of Atazanavir (ATV)/Ritonavir (RTV)CompletedNCT01099579Phase 3Results posted
• Study on the Usage, Dosing, Tolerability, and Effectiveness of Kaletra TabletCompletedNCT01097655Results posted
• Study to Evaluate the Safety and Efficacy of Stribild Versus Atripla in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive AdultsCompletedNCT01095796Phase 3Results posted
• Study of Vitamin D and Effect on Heart Disease and Insulin ResistanceCompletedNCT01093417Phase 2Results posted
• Vitamin D Dose Finding StudyCompletedNCT01092338Phase 2Results posted
• Mesalamine to Reduce T Cell Activation in HIV InfectionCompletedNCT01090102Phase 4Results posted
• HIV and Fat AccumulationCompletedNCT01088295Phase 2Results posted
• Sustiva Levels With Use of a Gel CapsuleCompletedNCT01087814Phase 4Results posted
• Evaluation of Kaletra Therapy Over the Long-termCompletedNCT01083810Results posted
• Safety and Efficacy Study of Serostim® Human Immunodeficiency Virus-Associated Adipose Redistribution SyndromeCompletedNCT01077960Phase 3Results posted
• Alcohol Pharmacotherapy for HIV+ PrisonersCompletedNCT01077310Not applicableResults posted
• Special Investigation of Kaletra in Pregnant WomenCompletedNCT01076985Results posted
• Drug Use Investigation of KaletraCompletedNCT01076972Results posted
• Kaletra in Combination With Antiretroviral AgentsCompletedNCT01076179Results posted
• Kaletra: Therapy With Double Protease InhibitorsCompletedNCT01075191Results posted
• Kaletra and Maraviroc in Antiretroviral Therapy (ART)-Naive Patients (KALMAR Study)TerminatedNCT01068873Phase 4Results posted
• Evaluating Strategies to Reduce Mother-to-Child Transmission of HIV Infection in Resource-Limited CountriesCompletedNCT01061151Phase 3Results posted
• Fosamprenavir in Pts With Hepatic ImpairmentCompletedNCT01054586Results posted
• Effect of Seminal Fluid on the Colon Wall; Implications for HIV TransmissionCompletedNCT01053741Not applicableResults posted
• Management of Human Immunodeficiency Virus 1 (HIV-1) Participants Treated With Antiretroviral (ARV) Combination Therapy Including Raltegravir (MK-0518-138)CompletedNCT01048671Results posted
• The Impact of Omega Three Fatty Acids on Vascular Function in HIVCompletedNCT01041521Phase 4Results posted
• Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected FemalesCompletedNCT01031069Phase 4Results posted
• Triomune Bioequivalence With InnovatorsCompletedNCT01025830Phase 4Results posted
• HIV Persistence and Viral ReservoirsCompletedNCT01025427Phase 4Results posted
• Safety and Efficacy of Reduced Versus Standard Dose Efavirenz (EFV) Plus Two Nucleotides in Antiretroviral-naïve Adults.CompletedNCT01011413Phase 3Results posted
• Pharmacodynamics, Safety and Pharmacokinetics of BMS-663068, an HIV Attachment Inhibitor, in HIV-1CompletedNCT01009814Phase 2Results posted
• Immunization With HIV-1 Peptides in Adjuvant for Treatment of Patients With Chronic HIV-infectionCompletedNCT01009762Phase 1Results posted
• Artery Elasticity After Switch From Epzicom to TruvadaTerminatedNCT00998582Phase 4Results posted
• Safety of and Immune Response to an H1N1 Influenza Virus Vaccine in HIV Infected Children and YouthCompletedNCT00992836Phase 2Results posted
• Durability of Adherence in Self-Management of HIVCompletedNCT00991302Not applicableResults posted
• Telephone Support to Improve Adherence to Anti-HIV MedicationsTerminatedNCT00988442Phase 2Results posted
• Maraviroc Intensification and Peripheral Blood Monocyte HIV DNA LevelsCompletedNCT00987948Phase 2Results posted
• Pharmacokinetics of Lopinavir/Ritonavir at Three Different Doses.CompletedNCT00985543Phase 1Results posted
• The Maraviroc Central Nervous System (CNS) StudyCompletedNCT00982878Phase 1Results posted
• The Raltegravir and Ribavirin Pharmacokinetics (PK) StudyCompletedNCT00982553Phase 1Results posted
• Cardiovascular Prevention for Persons With HIVCompletedNCT00982189Not applicableResults posted
• TMC125-TiDP35-C239 - Continued Access to Etravirine (ETR) in Treatment Experienced HIV-1 Infected ParticipantsCompletedNCT00980538Phase 3Results posted
• Non-interventional Observational Study With Viramune (Nevirapine) and Various Drug Combinations in the Antiretroviral Combination Treatment of HIV-infected Patients Who Have Already Been Treated for Approx. 10 Years With ViramuneCompletedNCT00979420Results posted
• Therapeutic Intensification Plus Immunomodulation to Decrease the HIV-1 Viral ReservoirCompletedNCT00976404Phase 2Results posted
• Evaluating Once Daily Etravirine in Treatment-Naive Adults With HIV InfectionCompletedNCT00959894Phase 2Results posted
• To Assess Neuroinflammation and Neurocognitive Function in Patients With Acute Hepatitis C and Chronic HIV Co-InfectionCompletedNCT00959166Not applicableResults posted
• IMPAACT 1077HS: Examining Benefits of HAART Continuation in Postpartum WomenCompletedNCT00955968Phase 4Results posted
• A Dose Ranging Trial of GSK1349572 and 2 NRTI in HIV-1 Infected, Therapy Naive SubjectsCompletedNCT00951015Phase 2Results posted
• Exercise, Oxidative Stress and HIVCompletedNCT00950937Results posted
• A Pilot Study Assessing the Integrase Inhibitor GSK1349572 in HIV-infected Persons With Virus Resistant to RaltegravirCompletedNCT00950859Phase 2Results posted
• Interventions for HIV Negative Men and Women Who Have High-risk Suspected Exposure to HIVCompletedNCT00949234Phase 2Results posted
• Safety and Tolerability Study to Evaluate Lower Dose of GSK2248761 in Antiretroviral Treatment-Naive HIV-1 Infected Adults.CompletedNCT00945282Phase 2Results posted
• Equivalence of Boosted Atazanavir Based Regimens and Currently Effective HAART RegimensCompletedNCT00940771Phase 4Results posted
• A Trial of 2 Options for Second Line Combination Antiretroviral Therapy Following Virological Failure of a Standard Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)+2N(t)RTI First Line RegimenCompletedNCT00931463Phase 4Results posted
• Evaluation of Three Strategies of Second-line Antiretroviral Treatment in Africa (Dakar - Bobo-Dioulasso - Yaoundé)CompletedNCT00928187Phase 3Results posted
• Computerized Cognitive Rehabilitation in Ugandan Children With HIVCompletedNCT00926003Not applicableResults posted
• CCR5 Inhibitor Treatment Intensification on CD4+ T-cell RecoveryCompletedNCT00925756Phase 4Results posted
• Treatment of Acute HIV With Emtricitabine, Tenofovir and Efavirenz (CID 0805)CompletedNCT00924898Phase 4Results posted
• Safety and Effectiveness of Alendronate for Bone Mineral Density in HIV-infected Children and AdolescentsCompletedNCT00921557Phase 2Results posted
• Study to Compare the Safety and Anti-HIV Effect of GSK1265744 Versus Placebo in HIV-1 Infected Adults (ITZ112929)CompletedNCT00920426Phase 2Results posted
• A Safety Study to Evaluate the Antiviral Activity of Darunavir in Combination With Ritonavir in HIV 1 Infected ChildrenCompletedNCT00919854Phase 2Results posted
• Comparing Blood Vessel Endothelial Function in HIV-Infected People and Matched HIV-Uninfected PeopleCompletedNCT00919724Results posted
• New Era Study: Treatment With Multi Drug Class (MDC) HAART in HIV Infected PatientsCompletedNCT00908544Not applicableResults posted
• A Phase I Multiple Dose Pharmacokinetic Study of Nevirapine Extended Release (XR) in HIV-1 Infected Children.CompletedNCT00905489Phase 1Results posted
• HIV and Kidney Function StudyCompletedNCT00905151Results posted
• A Clinical Trial Comparing the Tolerability of Etravirine to Efavirenz in Combination With 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Treatment-naive HIV-1 Infected PatientsCompletedNCT00903682Phase 2Results posted
• TMC125-TiDP2-C238: An Exploratory Pharmacokinetics, Safety and Anti-HIV Activity Study of Etravirine (ETR) When Given With Boosted Atazanavir (ATV/Rtv) at Two Different Doses and 1 Nucleoside Reverse Transcriptase Inhibitor (NRTI) in Treatment Experienced HIV PatientsCompletedNCT00896051Phase 2Results posted
• Prevalence and Predictors of Neurocognitive Impairment Among HIV-infected PatientsCompletedNCT00893815Results posted
• Immune Reconstitution as a Determinant of Adverse Effects to New Antiretroviral Therapy in Persons With Advanced HIV InfectionCompletedNCT00885664Phase 4Results posted
• Darunavir/Ritonavir and Rosuvastatin Pharmacokinetic StudyCompletedNCT00885495Phase 1/2Results posted
• Atazanavir and Lamivudine for Treatment SimplificationCompletedNCT00885482Phase 4Results posted
• Pilot Study on the Effect of Adding Raltegravir +/- a Second Drug on HIV Levels in the GutCompletedNCT00884793Not applicableResults posted
• Non-Interventional Observational Study With Viramune Plus Antiretroviral in HIV Infected PatientsCompletedNCT00876733Results posted
• A Pilot Project of Virologic, Pharmacologic and Immunologic Correlates of Gastrointestinal-Associated Lymphoid Tissue Immune Reconstitution Following Maraviroc TherapyCompletedNCT00870363Phase 4Results posted
• Study of the Safety and Efficacy of Stribild Versus Atripla in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive AdultsCompletedNCT00869557Phase 2Results posted
• Strategic Timing of Antiretroviral TreatmentCompletedNCT00867048Phase 4Results posted
• Safety and Effectiveness of HIV-1 DNA Plasmid Vaccine and HIV-1 Recombinant Adenoviral Vector Vaccine in HIV-Uninfected, Circumcised Men and Male-to-Female (MTF) Transgender Persons Who Have Sex With MenTerminatedNCT00865566Phase 2Results posted
• Combination Pain Therapy in HIV NeuropathyTerminatedNCT00863057Phase 2Results posted
• Buprenorphine/Raltegravir Pharmacokinetic Interaction StudyCompletedNCT00858962Not applicableResults posted
• HIV Viremia and Persistence in Acutely HIV-Infected Patients Treated With Darunavir/Ritonavir and EtravirineTerminatedNCT00855413Phase 4Results posted
• A Single-arm, Open-label, Study to Assess the Pharmacokinetics of Darunavir and Ritonavir, Darunavir and Cobicistat, Etravirine, and Rilpivirine in HIV-1 Infected Pregnant WomenCompletedNCT00855335Phase 3Results posted
• Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular ParametersCompletedNCT00851799Results posted
• A Study of Safety, Tolerability, and Immunogenicity of the MRKAd5 Gag/Pol/Nef Vaccine in Healthy Adults (V520-016)CompletedNCT00849680Phase 1Results posted
• Clinical Study of TUTI-16 in Asymptomatic HIV-1 Infected SubjectsCompletedNCT00848211Phase 1/2Results posted

← HIV Infections overview